JP2024538097A - Trem組成物及び使用方法 - Google Patents
Trem組成物及び使用方法 Download PDFInfo
- Publication number
- JP2024538097A JP2024538097A JP2024522280A JP2024522280A JP2024538097A JP 2024538097 A JP2024538097 A JP 2024538097A JP 2024522280 A JP2024522280 A JP 2024522280A JP 2024522280 A JP2024522280 A JP 2024522280A JP 2024538097 A JP2024538097 A JP 2024538097A
- Authority
- JP
- Japan
- Prior art keywords
- trem
- modification
- domain
- natural
- seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/113—Non-coding nucleic acids modulating the expression of genes, e.g. antisense oligonucleotides; Antisense DNA or RNA; Triplex- forming oligonucleotides; Catalytic nucleic acids, e.g. ribozymes; Nucleic acids used in co-suppression or gene silencing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
- A61K9/51—Nanocapsules; Nanoparticles
- A61K9/5107—Excipients; Inactive ingredients
- A61K9/5123—Organic compounds, e.g. fats, sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/31—Chemical structure of the backbone
- C12N2310/315—Phosphorothioates
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/321—2'-O-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/30—Chemical structure
- C12N2310/32—Chemical structure of the sugar
- C12N2310/322—2'-R Modification
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2310/00—Structure or type of the nucleic acid
- C12N2310/50—Physical structure
- C12N2310/53—Physical structure partially self-complementary or closed
- C12N2310/531—Stem-loop; Hairpin
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Genetics & Genomics (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Physics & Mathematics (AREA)
- General Health & Medical Sciences (AREA)
- Plant Pathology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Optics & Photonics (AREA)
- Animal Behavior & Ethology (AREA)
- Nanotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Cosmetics (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Detergent Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (9)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202163255426P | 2021-10-13 | 2021-10-13 | |
| US202163255420P | 2021-10-13 | 2021-10-13 | |
| US63/255,426 | 2021-10-13 | ||
| US63/255,420 | 2021-10-13 | ||
| US202163284946P | 2021-12-01 | 2021-12-01 | |
| US202163284934P | 2021-12-01 | 2021-12-01 | |
| US63/284,934 | 2021-12-01 | ||
| US63/284,946 | 2021-12-01 | ||
| PCT/US2022/046632 WO2023064513A2 (en) | 2021-10-13 | 2022-10-13 | Trem compositions and methods of use |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2024538097A true JP2024538097A (ja) | 2024-10-18 |
| JP2024538097A5 JP2024538097A5 (cg-RX-API-DMAC7.html) | 2025-10-22 |
Family
ID=85987785
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2024522280A Pending JP2024538097A (ja) | 2021-10-13 | 2022-10-13 | Trem組成物及び使用方法 |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US20240401047A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4416288A2 (cg-RX-API-DMAC7.html) |
| JP (1) | JP2024538097A (cg-RX-API-DMAC7.html) |
| KR (1) | KR20240107319A (cg-RX-API-DMAC7.html) |
| CN (1) | CN120418430A (cg-RX-API-DMAC7.html) |
| AU (1) | AU2022362286A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3235264A1 (cg-RX-API-DMAC7.html) |
| IL (1) | IL311867A (cg-RX-API-DMAC7.html) |
| MX (1) | MX2024004568A (cg-RX-API-DMAC7.html) |
| TW (1) | TW202325313A (cg-RX-API-DMAC7.html) |
| WO (1) | WO2023064513A2 (cg-RX-API-DMAC7.html) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2025080866A1 (en) * | 2023-10-10 | 2025-04-17 | Hc Bioscience, Inc. | Trna therapeutics for hemophilia |
| CN117805381B (zh) * | 2024-02-29 | 2024-05-28 | 首都医科大学附属北京积水潭医院 | 检测Gasdermin蛋白家族的物质在制备检测骨肉瘤的产品中的应用 |
| WO2026073261A1 (en) * | 2024-09-30 | 2026-04-02 | Flagship Pioneering Innovations Vi, Llc | Lipid nanoparticle formulations of trems |
| WO2026080471A2 (en) * | 2024-10-07 | 2026-04-16 | Flagship Pioneering Innovations Vi, Llc | Compositions of trem conjugates and uses thereof |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP5679147B2 (ja) * | 2008-02-07 | 2015-03-04 | 独立行政法人理化学研究所 | 非天然塩基を含む改変tRNA及びその用途 |
| WO2020069194A1 (en) * | 2018-09-26 | 2020-04-02 | Case Western Reserve University | Methods and compositions for treating a premature stop codon-mediated disorder |
| JP2022534988A (ja) * | 2019-05-31 | 2022-08-04 | フラッグシップ パイオニアリング, インコーポレイテッド | tRNAプールを調節するためのTREMの使用 |
| JP7712270B2 (ja) * | 2019-11-01 | 2025-07-23 | テバード バイオサイエンシズ インコーポレイテッド | 未成熟終止コドン媒介障害を処置するための方法および組成物 |
| WO2021142343A1 (en) * | 2020-01-09 | 2021-07-15 | The Regents Of The University Of California | Targeting transfer rna for the suppression of nonsense mutations in messenger rna |
| BR112022020780A2 (pt) * | 2020-04-14 | 2022-11-29 | Flagship Pioneering Innovations Vi Llc | Composições de trem e usos das mesmas |
| US20230203510A1 (en) * | 2020-05-29 | 2023-06-29 | Flagship Pioneering Innovations Vi, Llc | Trem compositions and methods relating thereto |
| KR20230135585A (ko) * | 2020-12-23 | 2023-09-25 | 플래그쉽 파이어니어링 이노베이션스 브이아이, 엘엘씨 | 변형된 trem의 조성물 및 이의 용도 |
-
2022
- 2022-10-13 CA CA3235264A patent/CA3235264A1/en active Pending
- 2022-10-13 JP JP2024522280A patent/JP2024538097A/ja active Pending
- 2022-10-13 CN CN202280082783.5A patent/CN120418430A/zh active Pending
- 2022-10-13 KR KR1020247015828A patent/KR20240107319A/ko active Pending
- 2022-10-13 EP EP22818139.2A patent/EP4416288A2/en active Pending
- 2022-10-13 MX MX2024004568A patent/MX2024004568A/es unknown
- 2022-10-13 AU AU2022362286A patent/AU2022362286A1/en active Pending
- 2022-10-13 TW TW111138921A patent/TW202325313A/zh unknown
- 2022-10-13 WO PCT/US2022/046632 patent/WO2023064513A2/en not_active Ceased
- 2022-10-13 IL IL311867A patent/IL311867A/en unknown
- 2022-10-13 US US18/700,523 patent/US20240401047A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| US20240401047A1 (en) | 2024-12-05 |
| AU2022362286A1 (en) | 2024-05-02 |
| TW202325313A (zh) | 2023-07-01 |
| MX2024004568A (es) | 2024-06-28 |
| WO2023064513A9 (en) | 2024-08-02 |
| WO2023064513A3 (en) | 2023-06-15 |
| KR20240107319A (ko) | 2024-07-09 |
| CN120418430A (zh) | 2025-08-01 |
| WO2023064513A2 (en) | 2023-04-20 |
| EP4416288A2 (en) | 2024-08-21 |
| IL311867A (en) | 2024-06-01 |
| CA3235264A1 (en) | 2023-04-20 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US10731159B2 (en) | Cationic lipid | |
| JP7174109B2 (ja) | 腫瘍溶解性ウイルスベクター及びその使用 | |
| US12121531B2 (en) | TREM compositions and uses thereof | |
| WO2018232355A1 (en) | Rna antibodies | |
| TW200526624A (en) | Cyclic aryl derivatives containing with heteroaryl ring | |
| BR112019020175A2 (pt) | Derivados de indolina substituídos como inibidores da replicação viral da dengue | |
| JP2008208139A (ja) | 4環縮合複素環化合物及びそのhcvポリメラーゼ阻害剤としての利用 | |
| JP2024528540A (ja) | 遺伝子操作されたガイドrna及びポリヌクレオチド | |
| JP2023527413A (ja) | Trem組成物及びそれに関連する方法 | |
| WO2023064513A9 (en) | Trem compositions and methods of use | |
| UA125644C2 (uk) | ЗАМІЩЕНІ 5,6,7,8-ТЕТРАГІДРО[1,2,4]ТРИАЗОЛО[4,3-а]ПІРИДИН-3(2Н)-ОНИ ТА 2,5,6,7-ТЕТРАГІДРО-3Н-ПІРОЛО[2,1-с][1,2,4]ТРИАЗОЛ-3-ОНИ ТА ЇХ ЗАСТОСУВАННЯ | |
| TW202334425A (zh) | 一種dsrna、其製備方法及應用 | |
| TW202340463A (zh) | 調節補體因子b之組合物及其使用方法 | |
| FR2763845A1 (fr) | Produits anti-cancereux pour le traitement de la mucoviscidose | |
| EP1549351A1 (en) | Use of an npy y2 receptor antagonist for treating disorders related to angiogenesis | |
| TW202322825A (zh) | 前微血管增滲素調節組合物及其使用方法 | |
| TWI318202B (en) | Oligo acid derivatives | |
| AU2024255972A1 (en) | Modified trems, compositions, and related methods thereof | |
| JP2026514001A (ja) | Trem組成物及びその使用方法 | |
| US20090162349A1 (en) | Method for prevention or treatment of diseases or disorders related to excessive formation of vascular tissue or blood vessels |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A524 | Written submission of copy of amendment under article 19 pct |
Free format text: JAPANESE INTERMEDIATE CODE: A524 Effective date: 20240830 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20251014 |
|
| A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20251014 |